| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |